Drugs in Ophthalmology for MS/DNB Ophthalmology Residents and Practicing Ophthalmologists | Ocular Pharmacotherapy Reference with Drug Classes, Delivery Systems and Rational Prescribing: 1

Drugs in Ophthalmology is a dedicated ocular pharmacology reference that bridges clinical ophthalmology and applied pharmacology in a single, clinically oriented text. Rather than focusing on diagnosis or surgical technique, it concentrates on the rational selection, mechanism, dosing, safety, and evidence-based use of drugs in everyday ophthalmic practice. Structured across 15 chapters, the book moves from the fundamentals of ocular pharmacokinetics and pharmacodynamics through disease-specific pharmacotherapy for infectious, allergic, dry eye and ocular surface, glaucomatous, intraocular inflammatory, retinal and vitreous, and pediatric ocular conditions, before covering mydriatics and miotics, ocular anesthesia and perioperative drugs, diagnostic dyes, and systemic drugs with ocular side effects. A dedicated chapter maps conventional ocular drug delivery across topical, systemic, periocular and intraocular routes alongside newer delivery technologies, including sustained-release implants, intracanalicular inserts, drug-eluting contact lenses, nanoparticle and mucoadhesive systems, and ocular gene therapy. Who This Book Is For: Ophthalmology postgraduates and residents (MS/DNB): Chapter-wise pharmacotherapy of major ocular disease groups, comparative drug tables, and delivery-system flowcharts for clinical postings and postgraduate exam preparation. Practicing ophthalmologists: A rational-prescribing reference for anti-infective, antiglaucoma, anti-inflammatory, and intravitreal drug choices, including newer delivery systems entering routine practice. Why This Book Helps: Clarifies mechanism-based prescribing: Links drug class and mechanism to specific ocular conditions instead of listing drugs in isolation. Demystifies ocular drug delivery: Classifies topical, systemic, periocular and intraocular routes and explains why the eye's own barriers limit conventional dosing. Keeps pace with newer therapeutics: Covers intravitreal anti-VEGF agents, sustained-release implants, and gene therapy alongside conventional drug classes. Flags safety early: Dedicates a chapter to systemic drugs with ocular side effects. Speeds revision: Chapter-opening learning objectives and comparative tables condense pharmacotherapy for quick review. Key Features: 15 chapters spanning ocular pharmacokinetics and pharmacodynamics through disease-specific pharmacotherapy for infectious, allergic, dry eye, glaucoma, intraocular inflammatory, retinal-vitreous and pediatric ocular conditions. A dedicated chapter comparing conventional and newer ocular drug delivery systems, with classification flowcharts and side-by-side comparison tables. A standalone chapter on systemic drugs with ocular side effects. Separate chapters on mydriatics and miotics, ocular anesthesia and perioperative drugs, and diagnostic dyes. Chapter-opening learning objectives and step-by-step instillation and injection technique guidance.

Disclaimer:

• Drugs in Ophthalmology for MS/DNB Ophthalmology Residents and Practicing Ophthalmologists | Ocular Pharmacotherapy Reference with Drug Classes, Delivery Systems and Rational Prescribing: 1 book is not for reading online or for free download in PDF or eBook format.
• Table of Contents, Index, Syllabus, summary and image of Drugs in Ophthalmology for MS/DNB Ophthalmology Residents and Practicing Ophthalmologists | Ocular Pharmacotherapy Reference with Drug Classes, Delivery Systems and Rational Prescribing: 1 may be of a different edition or of the same title.
• Price can change due to reprinting, price change by publisher or sourcing cost change for imported books.